Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Japan | 2021

Although it will be impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Japan will grow at a moderate rate through 2029, driven by rising surgical procedure volumes, the introduction of new products, and expanding indications for the existing products. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Biosurgical Agents in Japan across a 10-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…
Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…
Report
Small-Joint Reconstructive Implants – Market Insights – Japan
The Japanese smalljoint reconstructive implant market, covering shoulder and elbow arthroplasty, exhibits longterm growth potential. Procedure volumes are rising steadily, driven by Japan’s…